3300 Duval Road,
Austin, Texas 78759
Rules-Based Medicine (RBM) is a multiplexed biomarker testing laboratory, provides comprehensive protein biomarker products and services based on its Multi-Analyte Profiling (MAP) technology platform.
Rules-Based Medicine was acquired by Myriad Genetics on June 01, 2011.
Join Mergr to view all 163 acquisitions of life science companies in 2011, including 17 acquisitions by private equity firms, and 146 by strategics.
Join Mergr to view this profile - and discover more life science acquisitions of companies like Rules-Based Medicine.
No obligation. Cancel anytime.